Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Proteomics|February 12, 2009
Actin, gelsolin and filamin-A are dynamic actors in the cytoskeleton remodelling contributing to the blood brain barrier phenotypeGwënaël Pottiez, Emmanuel Sevin, Roméo Cecchelli, et al.
International Journal of Molecular Sciences|November 9, 2019
A Miniaturized Pump Out Method for Characterizing Molecule Interaction with ABC TransportersEmmanuel Sevin, Lucie Dehouck, Romain Versele, et al.
Bulletin Du Cancer|June 11, 2011
Metastatic renal cancer: evolution of five complete response cases after the antiangiogenic discontinuationJulien Demiselle, Stéphanie Lheureux, Bénédicte Clarisse, et al.
International Journal of Pharmaceutics|July 27, 2007
Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitroYoussef Jallouli, Archibald Paillard, Jiang Chang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 31, 2018
Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetrationMarjolein Heymans, Emmanuel Sevin, Fabien Gosselet, et al.
International Journal of Molecular Sciences|September 23, 2022
TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier ModelRomain Versele, Emmanuel Sevin, Fabien Gosselet, et al.
Drug Discovery Today|October 29, 2011
Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discoveryElodie Vandenhaute, Emmanuel Sevin, Dorothée Hallier-Vanuxeem, et al.
Brain Research|November 11, 2008
Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro modelFabien Gosselet, Pietra Candela, Emmanuel Sevin, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Unusual short-term complete response to two regimens of cytotoxic chemotherapy in a patient with poorly differentiated thyroid carcinomaGeneviève Crouzeix, Jean-Jacques Michels, Emmanuel Sevin, et al.
EJNMMI Research|May 9, 2012
Sorafenib increases 18-FDG colic uptake: demonstration in patients with differentiated thyroid cancerRenaud Ciappuccini, Géraldine Trzepla, Natacha Heutte, et al.
Pageof 6